Mueller A R, Platz K P, Langrehr J M, Hoffman R A, Nussler A K, Nalesnik M, Billiar T R, Schraut W H
Department of Surgery, University of Pittsburgh, Pennsylvania 15261.
Transplantation. 1994 Dec 27;58(12):1309-16.
The effects of nitric oxide (NO) during small bowel preservation and reperfusion were studied in a rat model of heterotopic, syngeneic LEW-->LEW transplantation. A 6-hr preservation interval was chosen, which leads consistently to moderate graft injury permitting graft and recipient survival. To evaluate the function of NO during preservation and reperfusion, two inhibitors (NitroG-L-arginine methyl ester [L-NAME] and NG-monomethyl-L-arginine [NMA]) were administered and compared with a transplanted group receiving no treatment. The extent of preservation and reperfusion injury were delineated by histologic study and by the measurement of mucosal glutaminase on tissue specimens obtained 20 min after revascularization and 24 hr and 4 weeks postoperatively. Serum and mucosal NO(2-)+NO3- levels were determined at the same time points. Graft function and survival was inferior in all cases where NO production was inhibited. When recipients were treated with NO inhibitors, graft function and survival was more impaired when L-NAME was administered compared with NMA administration. Donor and graft pretreatment with NO inhibitors impaired graft function but not survival, and was less detrimental than recipient treatment. Mucosal NO(2-)+NO3- levels significantly increased in untreated transplanted animals 20 min after reperfusion. This increase was abolished in groups treated with NO inhibitors. Serum NO(2-)+NO3- levels increased significantly after 24 hr, and this increase was even more pronounced when NO inhibitors were administered. Furthermore, liver function deteriorated after inhibition of NO, indicating a more severe inflammatory response of the recipient after NO inhibition. These data indicate that mucosal NO production within the graft during preservation, and especially during reperfusion, has beneficial effects, but increased serum NO(2-)+NO3- levels coincided with inferior graft condition due to preservation and reperfusion injury.
在异位同基因LEW→LEW移植的大鼠模型中,研究了一氧化氮(NO)在小肠保存和再灌注过程中的作用。选择6小时的保存间隔,这会持续导致中度移植物损伤,从而使移植物和受体存活。为了评估NO在保存和再灌注过程中的功能,给予两种抑制剂(硝基-L-精氨酸甲酯[L-NAME]和NG-单甲基-L-精氨酸[NMA]),并与未接受治疗的移植组进行比较。通过组织学研究以及对血管再通后20分钟、术后24小时和4周获得的组织标本进行黏膜谷氨酰胺酶测量,来描绘保存和再灌注损伤的程度。在相同时间点测定血清和黏膜中NO(2-)+NO3-水平。在所有抑制NO产生的情况下,移植物功能和存活率均较差。当受体用NO抑制剂治疗时,与给予NMA相比,给予L-NAME时移植物功能和存活率受损更严重。供体和移植物用NO抑制剂预处理会损害移植物功能,但不影响存活率,且比受体治疗的损害性小。未治疗的移植动物在再灌注后20分钟时,黏膜NO(2-)+NO3-水平显著升高。在用NO抑制剂治疗的组中,这种升高被消除。血清NO(2-)+NO3-水平在24小时后显著升高,当给予NO抑制剂时这种升高更为明显。此外,抑制NO后肝功能恶化,表明NO抑制后受体的炎症反应更严重。这些数据表明,在保存期间,尤其是在再灌注期间,移植物内黏膜产生的NO具有有益作用,但由于保存和再灌注损伤,血清NO(2-)+NO3-水平升高与较差的移植物状况同时出现。